ETR:GXI - Gerresheimer Stock Price, News & Analysis

€67.85
-0.30 (-0.44 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
€67.60
Now: €67.85
€68.75
50-Day Range
€65.10
MA: €68.19
€72.30
52-Week Range
€51.10
Now: €67.85
€77.55
Volume55,695 shs
Average Volume140,925 shs
Market Capitalization$2.13 billion
P/E Ratio10.29
Dividend Yield1.69%
BetaN/A
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. Read More…

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-211-618100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.41 billion
Cash Flow€3.53 per share
Book Value€32.84 per share

Profitability

Miscellaneous

Employees9,867
Market Cap$2.13 billion
Next Earnings Date10/10/2019 (Estimated)
OptionableNot Optionable

Receive GXI News and Ratings via Email

Sign-up to receive the latest news and ratings for GXI and its competitors with MarketBeat's FREE daily newsletter.


Gerresheimer (ETR:GXI) Frequently Asked Questions

What is Gerresheimer's stock symbol?

Gerresheimer trades on the ETR under the ticker symbol "GXI."

When is Gerresheimer's next earnings date?

Gerresheimer is scheduled to release their next quarterly earnings announcement on Thursday, October 10th 2019. View Earnings Estimates for Gerresheimer.

What price target have analysts set for GXI?

12 equities research analysts have issued 12 month price objectives for Gerresheimer's stock. Their forecasts range from €50.00 to €87.00. On average, they anticipate Gerresheimer's stock price to reach €71.67 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for Gerresheimer.

What is the consensus analysts' recommendation for Gerresheimer?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last year. There are currently 3 sell ratings, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Gerresheimer.

Has Gerresheimer been receiving favorable news coverage?

Media coverage about GXI stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Gerresheimer earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Gerresheimer.

Who are some of Gerresheimer's key competitors?

What other stocks do shareholders of Gerresheimer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gerresheimer investors own include Haynes International (HAYN), Cronos Group (CRON), Cree (CREE), Capitala Finance (CPTA), Clearone (CLRO), Boston Private Financial (BPFH), Biocept (BIOC), Brainstorm Cell Therapeutics (BCLI), Asure Software (ASUR) and Acer Therapeutics (ACER).

Who are Gerresheimer's key executives?

Gerresheimer's management team includes the folowing people:
  • Mr. Dietmar Siemssen, CEO & Member of Management Board (Age 56)
  • Dr. Lukas Burkhardt, Member of Management Board (Age 40)
  • Ms. Katja Schnitzler, Group Director of Bus. Excellence & Continuous Improvement and Member of the Supervisory Board (Age 38)
  • Ms. Severine Camp, Corp. Sr. Director of Investor Relations
  • Mr. Jens Kürten, Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media

What is Gerresheimer's stock price today?

One share of GXI stock can currently be purchased for approximately €67.85.

How big of a company is Gerresheimer?

Gerresheimer has a market capitalization of $2.13 billion and generates $1.41 billion in revenue each year. Gerresheimer employs 9,867 workers across the globe.View Additional Information About Gerresheimer.

What is Gerresheimer's official website?

The official website for Gerresheimer is http://www.gerresheimer.com/.

How can I contact Gerresheimer?

Gerresheimer's mailing address is Klaus-Bungert-Strasse 4, DUESSELDORF, 40468, Germany. The company can be reached via phone at +49-211-618100.


MarketBeat Community Rating for Gerresheimer (ETR GXI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  200 (Vote Underperform)
Total Votes:  385
MarketBeat's community ratings are surveys of what our community members think about Gerresheimer and other stocks. Vote "Outperform" if you believe GXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel